Risk analysis of prostate cancer in practical, a multinational consortium, using 25 known prostate cancer susceptibility loci

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 7, 2015, Pages 1121-1129

  Al Olama, Ali Amin ^a   Benlloch, Sara ^a   Antoniou, Antonis C ^a   Giles, Grahamg ^b,c   Severi, Gianluca ^aw   Neal, David E ^d,e   Hamdy, Freddie C ^f,g   Donovan, Jenny L ^h   Muir, Kenneth ^i,j   Schleutker, Johanna ^k,l   Henderson, Brian E ^m   Haiman, Christopher A ^m   Schumacher, Fredrick R ^m   Pashayan, Nora ^a,n   Pharoah, Paul D P ^a   Ostrander, Elaine A ^o   Stanford, Janet L ^p,q   Batra, Jyotsna ^r   Clements, Judith A ^r   Chambers, Suzanne K ^s,t,u   Weischer, Maren ^v   Nordestgaard, Børge G ^v   Ingles, Sue A ^m   Sorensen, Karina D ^w   Orntoft, Torben F ^w   Park, Jong Y ^x   Cybulski, Cezary ^y   Maier, Christiane ^z   Doerk, Thilo ^aa   Dickinson, Joanne L ^ab   Cannon Albright, Lisa ^ac,ad   Brenner, Hermann ^ae,af   Rebbeck, Timothy R ^ag   Zeigler Johnson, Charnita ^ah   Habuchi, Tomonori ^ai   Thibodeau, Stephen N ^aj   Cooney, Kathleen A ^ak   Chappuis, Pierre O ^al   Hutter, Pierre ^al   Kaneva, Radka P ^am   Foulkes, William D ^an   Zeegers, Maurice P ^ao   Lu, Yong Jie ^ap   Zhang, Hong Wei ^aq   Stephenson, Robert ^ac   Cox, Angela ^ar   Southey, Melissa C ^c   Spurdle, Amanda B ^as   Gerald, Liesel Fitz ^b   Leongamornlert, Daniel ^at   Saunders, Edward ^at   Tymrakiewicz, Malgorzata ^at   Guy, Michelle ^at   Dadaev, Tokhir ^at   Little, Sarah J ^at   Govindasami, Koveela ^at   Sawyer, Emma ^at   Wilkinson, Rosemary ^at   Herkommer, Kathleen ^au   Hopper, John L ^c   Lophatonanon, Aritaya ^j,k   Rinckleb, Antje E ^z   Kote Jarai, Zsofia ^at   Eeles, Rosalind A ^at,av   Easton, Douglas F ^a   John, Esther ^ax   Joshi, Amit ^ax   Shahabi, Ahva ^ax   Marthick, James R ^ax   Stern, Mariana C ^ax   Corral, Roman ^ax   Wallace, David M A ^ax   Bhatt, R I ^ax   Subramonian, K ^ax   Arrand, John ^ax   Flanagan, Louise ^ax   Bradley, Sita Ann ^ax   Bollina, Prasad ^ax   Bonnington, Sue ^ax   Bradshaw, Lynne ^ax   Catto, James ^ax   Cooper, Debbie ^ax   Down, Liz ^ax   Doble, Andrew ^ax   Doherty, Alan ^ax   Durkan, Garrett ^ax   Elliott, Emma ^ax   Gillatt, David ^ax   Herbert, Pippa ^ax   Howson, Joanne ^ax   Jones, Mandy ^ax   Kockelbergh, Roger ^ax   Kumar, Rajeev ^ax   Holding, Peter ^ax   Kynaston, Howard ^ax   Lane, Athene ^ax   Lennon, Teresa ^ax   Lyons, Norma ^ax   Leung, Hing ^ax   Mason, Malcolm ^ax   Moody, Hilary ^ax   Powell, Philip ^ax   Paul, Alan ^ax   Prescott, Stephen ^ax   Rosario, Derek ^ax   O'Sullivan, Patricia ^ax   Thompson, Pauline ^ax   Tidball, Sarah ^ax   Brown, Paul M ^ax   George, Anne ^ax   Marsden, Gemma ^ax   Davis, Michael ^ax   Edwards, Stephen ^ax   Fisher, Cyril ^ax   Jameson, Charles ^ax   Page, Elizabeth ^ax   Pedersen, John ^ax   Aitken, Joanne ^ax   Gardiner, Robert A ^ax   Srinivasan, Srilakshmi ^ax   Lose, Felicity ^ax   Kedda, Mary Anne ^ax   Alexander, Kimberly ^ax   O'Mara, Tracy ^ax   Risbridger, Gail ^ax   Tilley, Wayne ^ax   Horvarth, Lisa ^ax   Heathcote, Peter ^ax   Wood, Glenn ^ax   Malone, Greg ^ax   Samaratunga, Hema ^ax   Saunders, Pamela ^ax   Eckert, Allison ^ax   Yeadon, Trina ^ax   Kerr, Kris ^ax   Collins, Angus ^ax   Turner, Megan ^ax   Foote, Simon J ^ax   Polanowski, Andrea ^ax   Mcwhirter, Rebekah M ^ax   Dwyer, Terrence ^ax   Blizzard, Christopher L ^ax   Popov, Elenko ^ax   Kachakova, Darina ^ax   Mitkova, Atanaska ^ax   Goranova, Teodora ^ax   Stancheva, Gergana ^ax   Beltcheva, Olga ^ax   Dodova, Rumyana ^ax   Vlahova, Aleksandrina ^ax   Dikov, Tihomir ^ax   Christova, Svetlana ^ax   Borre, Michael ^ax   Klarskov, Peter ^ax   Nielsen, Sune F ^ax   Iversen, Peter ^ax   Røder, Andreas ^ax   Bojesen, Stig E ^ax   Dieffenbach, Aida Karina ^ax   Luedeke, Manuel ^ax   Schrader, Mark ^ax   Hoegel, Josef ^ax   Vogel, Walther ^ax   Maattanen, Liisa ^ax   Tammela, Teuvo ^ax   Auvinen, Anssi ^ax   Tillmans, Lori ^ax   Riska, Shaun ^ax   Wang, Liang ^ax   Stram, Dan ^ax   Laurence, Kolonel ^ax   Pow Sang, Julio ^ax   Park, Hyun Y ^ax   Radlein, Selina ^ax   Rincon, Maria ^ax   Zachariah, Babu ^ax   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITY OF BRISTOL   (United Kingdom)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j UNIVERSITY OF WARWICK   (United Kingdom)

^k TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^l UNIVERSITY OF TURKU   (Finland)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁿ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^o NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^p Fred Hutchinson Cancer Research Center   (United States)

^q UNIVERSITY OF WASHINGTON   (United States)

^r QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^s GRIFFITH UNIVERSITY   (Australia)

^t CANCER COUNCIL QUEENSLAND   (Australia)

^u PROSTATE CANCER FOUNDATION OF AUSTRALIA   (Australia)

^v GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^w AARHUS UNIVERSITY HOSPITAL   (Denmark)

^x H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^y POMERANIAN MEDICAL UNIVERSITY   (Poland)

^z UNIVERSITY HOSPITAL ULM   (Germany)

^aa Hannover Biomedical Research School   (Germany)

^ab UNIVERSITY OF TASMANIA   (Australia)

^ac UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^ad VETERANS AFFAIRS MEDICAL CENTER   (United States)

^ae Division of Clinical Epidemiology and Aging Research   (Germany)

^af GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ag UNIVERSITY OF PENNSYLVANIA   (United States)

^ah THOMAS JEFFERSON UNIVERSITY   (United States)

^ai AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^aj MAYO CLINIC   (United States)

^ak UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^al GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^am MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^an MCGILL UNIVERSITY   (Canada)

^ao MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^ap QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^aq SECOND MILITARY MEDICAL UNIVERSITY   (China)

^ar UNIVERSITY OF SHEFFIELD   (United Kingdom)

^as QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^at INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^au TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^av INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^aw Human Genetics Foundation   (Italy)

^ax Human Genetics Foundation ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYGENIC RISK SCORE; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SCREENING TEST; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MIDDLE AGED; MULTICENTER STUDY; ODDS RATIO; PROSTATE TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84941788242     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0317     Document Type: Article

References (22)

1. Pashayan N, Duffy SW, Chowdhury S, Dent T, Burton H, Neal DE, et al. Polygenic susceptibility to prostate and breast cancer: implications for personalised screening. Br J Cancer 2011;104:1656-63.
2. Amin AlOlama A, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009;41:1058-60.
3. Eeles RA, Kote-Jarai Z, Amin Al Olama A, Giles GG, Guy M, Severi G, et al. Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet 2009;41:1116-21.
4. Eeles RA, Kote-Jarai Z, Giles GG, Amin Al Olama A, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;40:316-21.
5. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-8.
6. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39:631-7.
7. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008;40:281-3.
8. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007;39:977-83.
9. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007;39:638-44.
10. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008;40:310-5.
11. Kote-Jarai Z, Amin Al Olama A, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet 2011;43: 785-91.
12. MacInnis RJ, Antoniou AC, Eeles RA, Severi G, Guy M, McGuffog L, et al. Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies. Genet Epidemiol 2010;34: 42-50.
13. Eeles RA, Amin Al Olama A, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet 2013;45:385-2.
14. Ferlay J, Soerjomataram II, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
15. Antoniou AC, Beesley J, McGuffog L, SinilnikovaOM, Healey S, Neuhausen SL, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 2010;70:9742-54.
16. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 2001;21:1-18.
17. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 2003;25: 190-202.
18. Chatterjee N, Wheeler B, Sampson J, Hartge P, Chanock SJ, Park JH. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat Genet 2013;45: 400-5.
19. Amin Al Olama A, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, et al. A meta-analysis of 87, 040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet 2014;46:1103-9.
20. MacInnis RJ, Antoniou AC, Eeles RA, Severi G, Amin Al Olama A, McGuffog L, et al. A risk prediction algorithm based on family history and common genetic variants: Application to prostate cancer with potential clinical impact. Genet Epidemiol 2011;35:549-56.
21. Whitaker HC, Kote-Jarai Z, Ross-Adams H, Warren AY, Burge J, George A, et al. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS ONE 2010;5:e13363.
22. Aly M, Wiklund F, Xu J, Isaacs WB, Eklund M, D'Amato M, et al. Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm- 1 cohort study. Eur Urol 2011;60:21-8.